Displaying items by tag: department of neurology

The goal is an early warning system to block incipient seizures for patients where medications have failed.
UAB research suggests protein misfolding, perhaps caused by a reduction in a regulatory protein, could be associated with Parkinson’s disease.
UAB's study of CBD oil for intractable epilepsy, funded by the State of Alabama under Carly's Law, shows that CBD oil reduces seizure frequency and severity in patients with treatment-resistant epilepsy.
UAB is renewed for another five years in NeuroNEXT, a national clinical research program in brain disorders.
The body’s autonomic nervous system affects involuntary actions, such as heart beat and breathing, and UAB opens a new tool to help diagnose autonomic-related conditions.
A neuron model of Parkinson’s disease and Lewy body dementias shows defects that could suggest treatments to halt or reverse cognitive impairments before the neurons die.
UAB investigators look at a gene therapy technique that helps cells take out the trash.
New guidelines suggest exercise and cognitive training can help lower the risk of dementia for those with mild cognitive impairment.
UAB will participate in the National Institutes of Health SIREN Network, a series of clinical trials for out-of-hospital medical emergencies.
UAB will examine cognitive behavior therapy, a form of psychotherapy, that may help reduce the severity of non-epileptic seizures induced by traumatic brain injury.
New research from UAB shows that maintaining healthy dendritic spines — a component of neurons — may be protective against Alzheimer’s disease.
A UAB researcher’s work on gender and quality of life in myasthenia gravis has been named the top abstract at a major neuromuscular disease professional meeting.
Page 7 of 14